Impact of Disease-Modifying Treatments on the Longitudinal Evolution of Anti-JCV Antibody Index in Multiple Sclerosis

Background: Risk of natalizumab-related progressive multifocal leukoencephalopathy is associated with the presence of anti-JC-virus (JCV) antibodies. Objective: To investigate the impact of disease-modifying treatments (DMT) on the longitudinal evolution of anti-JCV antibody index. Methods: Patients...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Front Immunol
Auteurs principaux: Hegen, Harald, Walde, Janette, Bsteh, Gabriel, Auer, Michael, Wurth, Sebastian, Zinganell, Anne, Di Pauli, Franziska, Deisenhammer, Florian, Berger, Thomas
Format: Artigo
Langue:Inglês
Publié: Frontiers Media S.A. 2018
Sujets:
Immunology
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6209669/
https://ncbi.nlm.nih.gov/pubmed/30410486
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2018.02435
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires